Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice of Investment in Metaphore Biotechnologies, Inc. by CVC Fund “TOHO Ventures”
Notice Regarding Re-Request to Provide Additional Information on Large-Scale Purchases of Share Certificates, Etc.
Notice on Receipt of Response to Request to Provide Additional Information on Large-Scale Purchases of Share Certificates, Etc.
Notice of the Posting of a Gain on Sale of Investment Securities (Extraordinary Income)
Notice Regarding Request to Provide Additional Information on Large-Scale Purchases of Share Certificates, Etc.
Responding to Shareholders’ Request for a Lawsuit (Non-Prosecution)
TOHO HOLDINGS, Oct-Dec (3Q) Ordinary Profit Decreases by 22%, Current Fiscal Year Dividend Revised Upward by 30 Yen
[Summary] Financial Results for the Nine Months
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)
Notice Regarding the Revision of Dividend Forecasts for the Fiscal Year Ending March 2026
Notice on Receipt of Response to Request to Provide Information on Large-Scale Purchases of Share Certificates, Etc.
Conclusion of Capital and Business Alliance with Surv BioPharma Inc.
(Delayed) Notice on Request to Provide Information on Large-Scale Purchases of Share Certificates, Etc.
(delayed)Notice of Receipt of a Large-Scale Purchase Explanation Related to Large-Scale Purchases of Share Certificates, Etc.
Notice Regarding Receipt of Letter from 3D Investment Partners Pte. Ltd. Concerning Establishment of Third-Party Committee and Submission of Response
Notice of the Posting of a Gain on Sale of Investment Securities (Extraordinary Income)
Corporate Governance Report
Notice Concerning the Results of Share Buybacks and Completion of Acquisition
TOHO HOLDINGS, First Half Ordinary Profit Revised Downward to an Unexpected 3%Decrease
[Summary] Financial Results for the Six Months